Found 8 matching trials
Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)
PHASE4Prior research has identified profound sleep disruption in individuals with...
Location
University of California- San Francisco
Suvorexant for Treatment of AUD and PTSD
PHASE2This study is to determine if suvorexant (SUV) will reduce insomnia in 76 m...
Location
University of California - Los Angeles
Suvorexant 3 - PE-PC
PHASE4The goal of this clinical trial is to learn if combining suvorexant (a slee...
Location
San Francisco VA Health Care System
Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
PHASE2This study is designed to elucidate the role of the orexin neurotransmitter...
Location
Man Alive Inc., Lane Treatment Center
Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial
PHASE2The goal of this proof-of-concept clinical trial is to evaluate the initial...
Location
James J. Peters Veterans Affairs Medical Center
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
PHASE4Post-traumatic stress disorder (PTSD) is a common consequence of combat tha...
Location
VA Long Beach Healthcare System, Long Beach, CA
Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder
EARLY_PHASE1The goal of this double-blind clinical trial is to further explore if, how,...
Location
The Ohio State University
Suvorexant for Opioid/Stimulant Co-use
PHASE2This study will evaluate whether Suvorexant 20mg reduces drug use and cravi...
Location
Behavioral Pharmacology Research Unit at the Johns Hopkins Bayview Medical Center